Therefore, it is concluded that high dose of fenofibrate may inhibit the expression of Runx2 gene in osteoblasts, and thus have a negative effect on the bones of T2DM mice with dyslipidemia. Here, RUNX2 is linked to type 2 diabetes mellitus.